Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245206 · ClinicalTrials.gov registry record · Phase 4
Side Effects of Newer Antipsychotics in Older Adults
A Phase 4 study, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 406
- Enrollment target
NCT00245206 is a Phase 4 study that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 406 participants.
The verdict
NCT00245206, a Phase 4 study, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 406 participants
- Enrollment target
Study Summary
This study will compare four atypical antipsychotic medications in terms of the risk of specific side effects each of them presents in middle-aged and elderly individuals.
Interventions
- DRUG Risperidone
- DRUG Olanzapine
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00245206
The ClinicalTrials.gov registry entry for NCT00245206 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Risperidone is the first listed.
NCT00245206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00245206 about?
NCT00245206 is a clinical study titled "Side Effects of Newer Antipsychotics in Older Adults". This study will compare four atypical antipsychotic medications in terms of the risk of specific side effects each of them presents in middle-aged and elderly individuals.
What is the current status of trial NCT00245206?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 406 participants. The study started on 2005-08. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00245206?
The interventions under investigation include: Risperidone (DRUG), Olanzapine (DRUG), Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00245206?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.